Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-7 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24	5.59e-09	37	138	7	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-7 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24	6.82e-09	38	138	7	GO:0070001
GeneOntologyMolecularFunction	structural molecule activity	ERVK-6 MXRA5 MAP1B PPFIA2 SPTB ERVK13-1 CLDN25 ERVK-7 ACTL7A FBLN2 LLGL1 HMCN1 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 TNXB	4.31e-05	891	138	18	GO:0005198
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-7 ERVK-8	5.12e-05	11	138	3	GO:0004523
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 ERVK-7 ERVK-8	1.11e-04	14	138	3	GO:0003964
GeneOntologyMolecularFunction	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-8 DNASE1	2.85e-04	46	138	4	GO:0016893
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-6 ERVK-7 ERVK-8	3.92e-04	21	138	3	GO:0035613
GeneOntologyMolecularFunction	phosphatidylinositol bisphosphate phosphatase activity	INPP5K PIKFYVE MTMR2	8.37e-04	27	138	3	GO:0034593
MousePheno	abnormal embryonic/fetal subventricular zone morphology	EBF1 PIKFYVE EML1 PRDM15 HTT	1.14e-05	41	102	5	MP:0004274
Domain	Ig-like_fold	IL10RA PRTG LILRA1 MXRA5 COL20A1 HLA-DQB2 HLA-DRB5 CEACAM4 LINGO3 EBF1 NECTIN3 PKHD1L1 LRIT3 IGSF10 SNED1 NEO1 PTPRB HMCN1 PRKAB1 FCRLB ILDR1 FCRL5 IGSF1 KIR3DL2 IL2RB TNXB SDK1 PLXNA2 EPHB1	6.70e-15	706	130	29	IPR013783
Domain	-	IL10RA PRTG LILRA1 MXRA5 COL20A1 HLA-DQB2 HLA-DRB5 CEACAM4 LINGO3 EBF1 NECTIN3 PKHD1L1 LRIT3 IGSF10 SNED1 NEO1 PTPRB HMCN1 FCRLB ILDR1 FCRL5 IGSF1 KIR3DL2 IL2RB TNXB SDK1 PLXNA2 EPHB1	1.06e-14	663	130	28	2.60.40.10
Domain	IG_LIKE	PRTG LILRA1 MXRA5 HLA-DQB2 HLA-DRB5 CEACAM4 LINGO3 NECTIN3 LRIT3 IGSF10 NEO1 HMCN1 FCRLB ILDR1 FCRL5 IGSF1 KIR3DL2 SDK1	8.93e-09	491	130	18	PS50835
Domain	Ig-like_dom	PRTG LILRA1 MXRA5 HLA-DQB2 HLA-DRB5 CEACAM4 LINGO3 NECTIN3 LRIT3 IGSF10 NEO1 HMCN1 FCRLB ILDR1 FCRL5 IGSF1 KIR3DL2 SDK1	1.30e-08	503	130	18	IPR007110
Domain	IG	PRTG LILRA1 MXRA5 CEACAM4 LINGO3 NECTIN3 LRIT3 IGSF10 NEO1 HMCN1 FCRLB ILDR1 FCRL5 IGSF1 KIR3DL2 SDK1	3.89e-08	421	130	16	SM00409
Domain	Ig_sub	PRTG LILRA1 MXRA5 CEACAM4 LINGO3 NECTIN3 LRIT3 IGSF10 NEO1 HMCN1 FCRLB ILDR1 FCRL5 IGSF1 KIR3DL2 SDK1	3.89e-08	421	130	16	IPR003599
Domain	FN3_dom	IL10RA PRTG COL20A1 LRIT3 SNED1 NEO1 PTPRB IL2RB TNXB SDK1 EPHB1	2.41e-07	209	130	11	IPR003961
Domain	FN3	PRTG COL20A1 LRIT3 SNED1 NEO1 PTPRB IL2RB TNXB SDK1 EPHB1	6.80e-07	185	130	10	SM00060
Domain	IGc2	PRTG LILRA1 MXRA5 LINGO3 LRIT3 IGSF10 NEO1 HMCN1 FCRL5 IGSF1 SDK1	7.73e-07	235	130	11	SM00408
Domain	Ig_sub2	PRTG LILRA1 MXRA5 LINGO3 LRIT3 IGSF10 NEO1 HMCN1 FCRL5 IGSF1 SDK1	7.73e-07	235	130	11	IPR003598
Domain	FN3	PRTG COL20A1 LRIT3 SNED1 NEO1 PTPRB IL2RB TNXB SDK1 EPHB1	1.32e-06	199	130	10	PS50853
Domain	fn3	PRTG COL20A1 SNED1 NEO1 PTPRB TNXB SDK1 EPHB1	1.79e-05	162	130	8	PF00041
Domain	Ig_I-set	PRTG MXRA5 LINGO3 LRIT3 IGSF10 NEO1 HMCN1 SDK1	5.58e-05	190	130	8	IPR013098
Domain	I-set	PRTG MXRA5 LINGO3 LRIT3 IGSF10 NEO1 HMCN1 SDK1	5.58e-05	190	130	8	PF07679
Domain	Leu-rich_rpt	MXRA5 LRTM1 LINGO3 LRRC8D LRIT3 FBXL6 IGSF10 CIITA CEP97	1.19e-04	271	130	9	IPR001611
Domain	Ig_2	LILRA1 NEO1 FCRLB FCRL5 IGSF1	1.56e-04	73	130	5	PF13895
Domain	LLGL	LLGL2 LLGL1	2.86e-04	4	130	2	PF08366
Domain	Lethal2_giant	LLGL2 LLGL1	2.86e-04	4	130	2	IPR000664
Domain	LLGL2	LLGL2 LLGL1	2.86e-04	4	130	2	IPR013577
Domain	-	MXRA5 LRTM1 LINGO3 LRRC8D LRIT3 FBXL6 IGSF10 CIITA CEP97	4.18e-04	321	130	9	3.80.10.10
Domain	L_dom-like	MXRA5 LRTM1 LINGO3 LRRC8D LRIT3 FBXL6 IGSF10 CIITA CEP97	4.88e-04	328	130	9	IPR032675
Domain	HELP	EML2 EML1	7.08e-04	6	130	2	PF03451
Domain	Myb-like_dom	EP400 SNAPC4	7.08e-04	6	130	2	IPR017877
Domain	HELP	EML2 EML1	7.08e-04	6	130	2	IPR005108
Domain	Growth_fac_rcpt_	CUBN GPR179 FBLN2 HMCN1 TNXB EPHB1	7.85e-04	156	130	6	IPR009030
Domain	IPT	EBF1 PKHD1L1 PLXNA2	8.53e-04	27	130	3	SM00429
Domain	LRR_1	LRTM1 LINGO3 LRRC8D LRIT3 FBXL6 CIITA CEP97	8.65e-04	219	130	7	PF00560
Domain	LRR_8	MXRA5 LRTM1 LINGO3 LRRC8D LRIT3 IGSF10	1.26e-03	171	130	6	PF13855
Domain	TIG	EBF1 PKHD1L1 PLXNA2	1.28e-03	31	130	3	PF01833
Domain	MHC_II_b_N	HLA-DQB2 HLA-DRB5	1.31e-03	8	130	2	PD000328
Domain	IPT	EBF1 PKHD1L1 PLXNA2	1.41e-03	32	130	3	IPR002909
Domain	LRR_TYP	MXRA5 LRTM1 LINGO3 LRRC8D LRIT3 IGSF10	1.51e-03	177	130	6	SM00369
Domain	Leu-rich_rpt_typical-subtyp	MXRA5 LRTM1 LINGO3 LRRC8D LRIT3 IGSF10	1.51e-03	177	130	6	IPR003591
Domain	MHC_II_b_N	HLA-DQB2 HLA-DRB5	1.68e-03	9	130	2	IPR000353
Domain	MHC_II_beta	HLA-DQB2 HLA-DRB5	1.68e-03	9	130	2	SM00921
Domain	MHC_II_beta	HLA-DQB2 HLA-DRB5	1.68e-03	9	130	2	PF00969
Domain	-	RBBP5 EML2 NBEA LLGL2 LLGL1 TECPR2 EML1 PLXNA2	2.32e-03	333	130	8	2.130.10.10
Domain	MYB_LIKE	EP400 NCOR2 SNAPC4	2.33e-03	38	130	3	PS50090
Domain	MHC_I/II-like_Ag-recog	HLA-DQB2 HLA-DRB5 RAET1E	2.33e-03	38	130	3	IPR011162
Domain	WD40/YVTN_repeat-like_dom	RBBP5 EML2 NBEA LLGL2 LLGL1 TECPR2 EML1 PLXNA2	2.41e-03	335	130	8	IPR015943
Domain	WD40	RBBP5 EML2 NBEA LLGL2 LLGL1 TECPR2 EML1	2.74e-03	268	130	7	SM00320
Domain	LRR	LRTM1 LINGO3 LRRC8D LRIT3 CIITA CEP97	2.85e-03	201	130	6	PS51450
Domain	WD40_repeat	RBBP5 EML2 NBEA LLGL2 LLGL1 TECPR2 EML1	2.97e-03	272	130	7	IPR001680
Domain	WD_REPEATS_1	RBBP5 EML2 NBEA LLGL2 LLGL1 TECPR2 EML1	3.35e-03	278	130	7	PS00678
Domain	WD_REPEATS_2	RBBP5 EML2 NBEA LLGL2 LLGL1 TECPR2 EML1	3.42e-03	279	130	7	PS50082
Domain	WD_REPEATS_REGION	RBBP5 EML2 NBEA LLGL2 LLGL1 TECPR2 EML1	3.42e-03	279	130	7	PS50294
Domain	Cys-rich_flank_reg_C	MXRA5 LRTM1 LINGO3 IGSF10	3.61e-03	90	130	4	IPR000483
Domain	LRRCT	MXRA5 LRTM1 LINGO3 IGSF10	3.61e-03	90	130	4	SM00082
Domain	MHC_II_a/b_N	HLA-DQB2 HLA-DRB5	4.14e-03	14	130	2	IPR014745
Domain	-	HLA-DQB2 HLA-DRB5	4.14e-03	14	130	2	3.10.320.10
Domain	EGF_Ca-bd_CS	CUBN SNED1 FBLN2 HMCN1	4.71e-03	97	130	4	IPR018097
Domain	WD40_repeat_dom	RBBP5 EML2 NBEA LLGL2 LLGL1 TECPR2 EML1	4.80e-03	297	130	7	IPR017986
Domain	LRRNT	MXRA5 LRTM1 LINGO3 IGSF10	4.89e-03	98	130	4	IPR000372
Domain	LRRNT	MXRA5 LRTM1 LINGO3 IGSF10	4.89e-03	98	130	4	SM00013
Domain	EGF_CA	CUBN SNED1 FBLN2 HMCN1	5.07e-03	99	130	4	PS01187
Domain	SANT	EP400 NCOR2 SNAPC4	5.09e-03	50	130	3	SM00717
Domain	ASX_HYDROXYL	CUBN SNED1 FBLN2 HMCN1	5.25e-03	100	130	4	PS00010
Domain	SANT/Myb	EP400 NCOR2 SNAPC4	5.68e-03	52	130	3	IPR001005
Domain	Ig_E-set	EBF1 PKHD1L1 PRKAB1 PLXNA2	6.03e-03	104	130	4	IPR014756
Domain	EGF	CUBN GPR179 SNED1 FBLN2 HMCN1 TNXB	6.08e-03	235	130	6	SM00181
Domain	EGF-type_Asp/Asn_hydroxyl_site	CUBN SNED1 FBLN2 HMCN1	6.44e-03	106	130	4	IPR000152
Domain	LH2	PKD1L1 LIPC	6.84e-03	18	130	2	SM00308
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-18 ERVK-19	1.25e-09	5	140	4	12629516
Pubmed	Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.	ERVK-6 ERVK-18 ERVK-19	6.38e-08	3	140	3	10516026
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-7 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24	1.13e-07	94	140	7	21542922
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-6 ERVK-7 ERVK-24	2.55e-07	4	140	3	10469592
Pubmed	Mycobacterium avium infection of mouse macrophages inhibits IFN-gamma Janus kinase-STAT signaling and gene induction by down-regulation of the IFN-gamma receptor.	HLA-DRB5 IRF1 CIITA	6.35e-07	5	140	3	10438942
Pubmed	Adult-onset Alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model.	IL10RA HLA-DQB2 HLA-DRB5 IL2RB	2.51e-06	24	140	4	15245428
Pubmed	Genetic Associations with Plasma B12, B6, and Folate Levels in an Ischemic Stroke Population from the Vitamin Intervention for Stroke Prevention (VISP) Trial.	CUBN RASIP1 FUT2	3.52e-06	8	140	3	25147783
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	PRTG NECTIN3 LRIT3 IGSF10 HMCN1 ILDR1 IGSF1	4.46e-06	162	140	7	25826454
Pubmed	Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway.	CUBN FIGN FUT2	5.27e-06	9	140	3	19744961
Pubmed	Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals.	HIPK2 HIPK3 PAX1	1.37e-05	12	140	3	16537918
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-6 ERVK-8 ERVK-19	1.37e-05	12	140	3	14557543
Pubmed	The tumor suppressor Lgl1 regulates NMII-A cellular distribution and focal adhesion morphology to optimize cell migration.	LLGL2 LLGL1	1.61e-05	2	140	2	22219375
Pubmed	Hugl1 and Hugl2 in mammary epithelial cells: polarity, proliferation, and differentiation.	LLGL2 LLGL1	1.61e-05	2	140	2	23110097
Pubmed	Essential cell-autonomous role for interferon (IFN) regulatory factor 1 in IFN-γ-mediated inhibition of norovirus replication in macrophages.	IRF1 CIITA	1.61e-05	2	140	2	22973039
Pubmed	Inhibition of HIPK3 by AST487 Ameliorates Mutant HTT-Induced Neurotoxicity and Apoptosis via Enhanced Autophagy.	HIPK3 HTT	1.61e-05	2	140	2	34741261
Pubmed	Aberrant expression of Fas ligand in mice deficient for the MHC class II transactivator.	HLA-DQB2 CIITA	1.61e-05	2	140	2	11970984
Pubmed	Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.	HLA-DQB2 CIITA	1.61e-05	2	140	2	16863914
Pubmed	Sequence and expression patterns of a human EMAP-related protein-2 (HuEMAP-2).	EML2 EML1	1.61e-05	2	140	2	10521658
Pubmed	Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.	ERVK-6 ERVK-19	1.61e-05	2	140	2	9060628
Pubmed	Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses.	ERVK-6 ERVK-19	1.61e-05	2	140	2	9460924
Pubmed	Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity.	ERVK-6 ERVK-18	1.61e-05	2	140	2	11672541
Pubmed	Post-developmental plasticity of the primary rod pathway allows restoration of visually guided behaviors.	LRIT3 GPR139 GPR179	1.77e-05	13	140	3	36179691
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	PPFIA2 GRID1 NEO1 EML1 IL2RB SDK1 EPHB1	2.72e-05	214	140	7	22199357
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	EP400 RTTN EML2 GRID1 PIKFYVE GDPD5 NCOR2 LLGL2 TTLL4 TMEM132A SNAPC4 BCL2L13 TTC38 SOWAHB HTT	4.17e-05	1105	140	15	35748872
Pubmed	Gene conversion between murine class II major histocompatibility complex loci. Functional and molecular evidence from the bm 12 mutant.	HLA-DQB2 HLA-DRB5	4.81e-05	3	140	2	6434690
Pubmed	Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies.	PIKFYVE MTMR2	4.81e-05	3	140	2	22028665
Pubmed	Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models.	HIPK3 HTT	4.81e-05	3	140	2	29151587
Pubmed	Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance.	HLA-DQB2 CIITA	4.81e-05	3	140	2	20431619
Pubmed	Mice with double knockout of H2-Eb1 and H2-Ab1 exhibit reduced susceptibility to allergic rhinitis.	HLA-DQB2 HLA-DRB5	4.81e-05	3	140	2	30372475
Pubmed	Activation of extracellular signal-regulated kinase but not of p38 mitogen-activated protein kinase pathways in lymphocytes requires allosteric activation of SOS.	HLA-DQB2 SOS1	4.81e-05	3	140	2	23589333
Pubmed	Mice lacking the transcription factor CIITA--a second look.	HLA-DQB2 CIITA	4.81e-05	3	140	2	9885917
Pubmed	PU.1 binds to a distal regulatory element that is necessary for B cell-specific expression of CIITA.	CIITA DNASE1	4.81e-05	3	140	2	20363966
Pubmed	Absence of MHC-II expression by lymph node stromal cells results in autoimmunity.	HLA-DQB2 CIITA	4.81e-05	3	140	2	30584641
Pubmed	Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells.	IRF1 CIITA	4.81e-05	3	140	2	16210330
Pubmed	Enhanced production of IL-10 by dendritic cells deficient in CIITA.	HLA-DQB2 CIITA	4.81e-05	3	140	2	15661876
Pubmed	The nucleotide sequence of the murine I-E beta b immune response gene: evidence for gene conversion events in class II genes of the major histocompatibility complex.	HLA-DQB2 HLA-DRB5	4.81e-05	3	140	2	6086309
Pubmed	Brucella abortus down-regulates MHC class II by the IL-6-dependent inhibition of CIITA through the downmodulation of IFN regulatory factor-1 (IRF-1).	IRF1 CIITA	4.81e-05	3	140	2	27765819
Pubmed	Distinct MHC class II molecules are associated on the dendritic cell surface in cholesterol-dependent membrane microdomains.	HLA-DQB2 HLA-DRB5	4.81e-05	3	140	2	20833718
Pubmed	Identification of rat EMAP, a delta-glutamate receptor binding protein.	GRID1 EML1	4.81e-05	3	140	2	11829466
Pubmed	Thymic selection pathway regulates the effector function of CD4 T cells.	HLA-DQB2 CIITA	4.81e-05	3	140	2	17724129
Pubmed	The Eb beta gene may have acted as the donor gene in a gene conversion-like event generating the Abm 12 beta mutant.	HLA-DQB2 HLA-DRB5	4.81e-05	3	140	2	6436017
Pubmed	Update on the Regulation of HIPK1, HIPK2 and HIPK3 Protein Kinases by microRNAs.	HIPK2 HIPK3	4.81e-05	3	140	2	29793420
Pubmed	Nucleotide sequence analysis of class II genes borne by mouse t chromosomes.	HLA-DQB2 HLA-DRB5	4.81e-05	3	140	2	3692165
Pubmed	Induction and maintenance of IL-4 expression are regulated differently by the 3' enhancer in CD4 T cells.	HLA-DQB2 DNASE1	4.81e-05	3	140	2	21282512
Pubmed	A study of associations between CUBN, HNF1A, and LIPC gene polymorphisms and coronary artery disease.	CUBN LIPC	4.81e-05	3	140	2	33004870
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-18 ERVK-25 ERVK-24	4.98e-05	18	140	3	18664271
Pubmed	Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA.	HLA-DQB2 HLA-DRB5 CIITA	4.98e-05	18	140	3	11118314
Pubmed	Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection.	HLA-DQB2 HLA-DRB5 CIITA	4.98e-05	18	140	3	10661406
Pubmed	Recombination in the class III region of the mouse major histocompatibility complex.	HLA-DQB2 HLA-DRB5 TNXB	9.30e-05	22	140	3	7916002
Pubmed	Estrogenic induction of spermatogenesis in the hypogonadal mouse.	HIPK2 HIPK3	9.60e-05	4	140	2	10919273
Pubmed	Mammalian Lgl forms a protein complex with PAR-6 and aPKC independently of PAR-3 to regulate epithelial cell polarity.	LLGL2 LLGL1	9.60e-05	4	140	2	12725730
Pubmed	Endosomal phosphoinositides and human diseases.	PIKFYVE MTMR2	9.60e-05	4	140	2	18429927
Pubmed	Regulation of IL-17 expression by the developmental pathway of CD4 T cells in the thymus.	HLA-DQB2 CIITA	9.60e-05	4	140	2	20080304
Pubmed	Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney.	SNAI2 CDH16	9.60e-05	4	140	2	17093497
Pubmed	Genetic variation at 5 new autosomal short tandem repeat markers (D10S1248, D22S1045, D2S441, D1S1656, D12S391) in a population-based sample from Maghreb region.	IL2RB SOS1	9.60e-05	4	140	2	21674833
Pubmed	Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK).	HIPK2 HIPK3	9.60e-05	4	140	2	25630557
Pubmed	Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations.	ASXL1 CSF3	9.60e-05	4	140	2	24216483
Pubmed	MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53.	MUC16 TSPYL5	9.60e-05	4	140	2	28196872
Pubmed	Gene trap expression and mutational analysis for genes involved in the development of the mammalian nervous system.	MAP1B RTTN	9.60e-05	4	140	2	9626495
Pubmed	Macroautophagy substrates are loaded onto MHC class II of medullary thymic epithelial cells for central tolerance.	HLA-DQB2 CIITA	9.60e-05	4	140	2	23382543
Pubmed	Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation.	HIPK2 HIPK3	9.60e-05	4	140	2	34785661
Pubmed	Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.	ERVK-6 ERVK-19	9.60e-05	4	140	2	7983737
Pubmed	PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival.	PQBP1 HTT	9.60e-05	4	140	2	10332029
Pubmed	Mutation screening of the LRIT3, CABP4, and GPR179 genes in Chinese patients with Schubert-Bornschein congenital stationary night blindness.	LRIT3 GPR179	9.60e-05	4	140	2	27428514
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MAP1B FAM53A PPFIA2 SPTB HIPK2 INTS8 LRRC8D HIPK3 NCOR2 PTPRB TECPR2 KLHL23 ELK4 CATSPERG PRDM15 ZMAT1 HTT	1.07e-04	1489	140	17	28611215
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	NECTIN3 CUBN DCBLD2 SDK1 PLXNA2	1.15e-04	117	140	5	17145500
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	COL20A1 FBLN2 HMCN1 TNXB	1.32e-04	64	140	4	22261194
Pubmed	Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2.	SPTB IL2RB SOS1	1.38e-04	25	140	3	8493579
Pubmed	LRIT3 is Required for Nyctalopin Expression and Normal ON and OFF Pathway Signaling in the Retina.	LRIT3 GPR179	1.60e-04	5	140	2	31959619
Pubmed	Species-specific evolution of the FcR family in endothermic vertebrates.	FCRLB FCRL5	1.60e-04	5	140	2	17356879
Pubmed	Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping.	ERVK-6 ERVK-7	1.60e-04	5	140	2	11401426
Pubmed	Nuclear localization of CBF1 is regulated by interactions with the SMRT corepressor complex.	INPP5K NCOR2	1.60e-04	5	140	2	11509665
Pubmed	Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice.	HLA-DQB2 CIITA	1.60e-04	5	140	2	9491996
Pubmed	Critical Role for the Microbiota in CX3CR1+ Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses.	IL10RA HLA-DQB2	1.60e-04	5	140	2	29980437
Pubmed	Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection.	HLA-DQB2 CIITA	1.60e-04	5	140	2	9164958
Pubmed	Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4⁺ T cell tolerance.	HLA-DQB2 CIITA	1.60e-04	5	140	2	24842370
Pubmed	Molecular mechanism and cellular function of MHCII ubiquitination.	HLA-DQB2 HLA-DRB5	1.60e-04	5	140	2	26085212
Pubmed	Mechanisms governing B cell developmental defects in invariant chain-deficient mice.	HLA-DQB2 CIITA	1.60e-04	5	140	2	14764672
Pubmed	Cathepsin E: a novel target for regulation by class II transactivator.	HLA-DQB2 CIITA	1.60e-04	5	140	2	15100295
Pubmed	A systematic screen for genes expressed in definitive endoderm by Serial Analysis of Gene Expression (SAGE).	PRTG CUBN ARG1	1.94e-04	28	140	3	17683524
Pubmed	Absence of MHC class II expression distinguishes fetal from adult B lymphopoiesis in mice.	HLA-DQB2 HLA-DRB5	2.39e-04	6	140	2	8176204
Pubmed	New nomenclature for Fc receptor-like molecules.	FCRLB FCRL5	2.39e-04	6	140	2	16622424
Pubmed	The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex.	HLA-DQB2 HLA-DRB5	2.39e-04	6	140	2	3003909
Pubmed	Involvement of the Hipk family in regulation of eyeball size, lens formation and retinal morphogenesis.	HIPK2 HIPK3	2.39e-04	6	140	2	20579985
Pubmed	Novel locus including FGF21 is associated with dietary macronutrient intake.	RASIP1 FUT2	2.39e-04	6	140	2	23372041
Pubmed	Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.	EP400 CIITA	2.39e-04	6	140	2	26871568
Pubmed	Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors.	HIPK2 HIPK3	2.39e-04	6	140	2	9748262
Pubmed	Endosomes are specialized platforms for bacterial sensing and NOD2 signalling.	HLA-DQB2 SLC15A4	2.39e-04	6	140	2	24695226
Pubmed	Sequence of class II major histocompatibility complex genes from MRL mice. Conserved amino acids in the I-E beta chains from autoimmune mice.	HLA-DQB2 HLA-DRB5	2.39e-04	6	140	2	1953819
Pubmed	Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity.	ERVK-6 ERVK-19	2.39e-04	6	140	2	15063128
Pubmed	PtdIns5P regulation through evolution: roles in membrane trafficking?	PIKFYVE MTMR2	2.39e-04	6	140	2	18774718
Pubmed	Linkage in the mouse: the sex-linked genes and Rough.	ATP7A PAX1	2.39e-04	6	140	2	13227156
Pubmed	Crystal structure of EML1 reveals the basis for Hsp90 dependence of oncogenic EML4-ALK by disruption of an atypical β-propeller domain.	EML2 EML1	2.39e-04	6	140	2	24706829
Pubmed	Mice lacking all conventional MHC class II genes.	HLA-DQB2 HLA-DRB5	2.39e-04	6	140	2	10468609
Pubmed	Homeodomain-interacting protein kinase 1 modulates Daxx localization, phosphorylation, and transcriptional activity.	HIPK2 HIPK3	2.39e-04	6	140	2	12529400
Pubmed	Two distinct domains within the N-terminal region of Janus kinase 1 interact with cytokine receptors.	IL10RA IL2RB	2.39e-04	6	140	2	12133952
Pubmed	Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development.	PPFIA2 NBEA NEO1	2.64e-04	31	140	3	25838543
Pubmed	A global genomic transcriptional code associated with CNS-expressed genes.	HIPK2 EBF1 FIGN HIPK3 GPR180 PLA2R1 IGSF1	3.18e-04	318	140	7	16919269
Pubmed	Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum.	EBF1 NECTIN3 FIGN	3.19e-04	33	140	3	18199763
Pubmed	A molecular map of the immune response region from the major histocompatibility complex of the mouse.	HLA-DQB2 HLA-DRB5	3.33e-04	7	140	2	6290895
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	PRTG MXRA5 LINGO3 NECTIN3 LRIT3 IGSF10 NEO1 HMCN1 SDK1	8.81e-08	161	88	9	593
GeneFamily	Fibronectin type III domain containing	PRTG COL20A1 SNED1 NEO1 PTPRB TNXB SDK1 EPHB1	1.11e-06	160	88	8	555
GeneFamily	Immunoglobulin like domain containing	MXRA5 NECTIN3 NEO1 FCRLB FCRL5 IGSF1 SDK1	4.33e-05	193	88	7	594
GeneFamily	Membrane associated guanylate kinases\|PDZ domain containing\|Scribble complex	LLGL2 LLGL1	1.40e-04	4	88	2	1224
GeneFamily	Fibulins	FBLN2 HMCN1	6.43e-04	8	88	2	556
GeneFamily	WD repeat domain containing	RBBP5 EML2 NBEA LLGL2 LLGL1 EML1	1.76e-03	262	88	6	362
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	EP400 NCOR2 SNAPC4	2.19e-03	53	88	3	532
Coexpression	BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP	IL10RA ERG MUC16 IRF1 GSAP NECTIN3 TEX14 GPR180 CSF3 ILDR1 ELK4 FUT2 BCL2L13 TTC38 SOWAHB	1.02e-06	644	133	15	M34026
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERG EBF1 PKHD1L1 SNED1 RASIP1 PTPRB HMCN1 TNXB	1.09e-07	190	133	8	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 PKHD1L1 RASIP1 PTPRB CIITA EML1 TNXB	1.28e-07	194	133	8	cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG HLA-DRB5 EBF1 RASIP1 PTPRB CIITA EML1 TNXB	1.28e-07	194	133	8	fa6d51f36a3dae8763a595c20892987ed454c0f0
ToppCell	10x5'-Liver-Lymphocytic_NK-NK_CD16\|Liver / Manually curated celltypes from each tissue	HIPK2 IRF1 GSAP LLGL2 SLC15A4 KIR3DL2 IL2RB TTC38	1.38e-07	196	133	8	e6d4853ccefbcd45a019cee595811f0474dcc036
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 SNED1 RASIP1 PTPRB CIITA EML1 TNXB	1.44e-07	197	133	8	cd509e49bbdbf991cc5913960ff3ef275ad40628
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 SNED1 RASIP1 PTPRB CIITA EML1 TNXB	1.44e-07	197	133	8	412cb5f37df57121ddd1492021445479c7cbccbf
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG HLA-DRB5 EBF1 RASIP1 FBLN2 PTPRB EML1 TNXB	1.49e-07	198	133	8	953630dbe3154b1b102b87de0feca2cbf124eabe
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG HLA-DRB5 EBF1 RASIP1 FBLN2 PTPRB EML1 TNXB	1.49e-07	198	133	8	8e45551224fbb30c0658ad47dd98335ecf165437
ToppCell	COVID-19_Mild-NK\|COVID-19_Mild / Disease condition and Cell class	HIPK2 IRF1 GSAP LLGL2 SLC15A4 KIR3DL2 IL2RB TTC38	1.61e-07	200	133	8	b586b0f1127293c2f8529be16b24229359041da2
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DQB2 HLA-DRB5 GRID1 EBF1 PIKFYVE CIITA FCRL5	1.70e-07	135	133	7	7743a01dc9c4542e910e7c0fe046004692a680bf
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 PKHD1L1 PTPRB EML1 TNXB SOWAHB	4.35e-07	155	133	7	babcb9e548f04ace8157d506d27c5941c692c491
ToppCell	10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_naive\|bone_marrow / Manually curated celltypes from each tissue	HLA-DQB2 HLA-DRB5 EBF1 PIKFYVE FBLN2 CIITA FCRL5	5.86e-07	162	133	7	44832055b11a789e320c802aadb345e065defc8f
ToppCell	Endothelial-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	ERG MAP1B EBF1 PKHD1L1 RASIP1 PTPRB TNXB	6.90e-07	166	133	7	c286987ea4e511195607c87ec4529c2c2ed2122e
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	MAP1B PPFIA2 HIPK2 GRID1 TMC4 EBF1 KLHL23	1.23e-06	181	133	7	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PCBP3 ERG EBF1 SNED1 RASIP1 PTPRB EML1	1.38e-06	184	133	7	688428103e8b19f45f2f65d70a0f30c904c8411c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 SNED1 RASIP1 PTPRB EML1 TNXB	1.53e-06	187	133	7	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PRTG RTTN FIGN FBLN2 EML1 SDK1 EPHB1	1.53e-06	187	133	7	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EBF1 NECTIN3 SSC5D FBLN2 DCBLD2 TNXB SDK1	1.59e-06	188	133	7	aa516273cdde53c8c0295f06830972388f890c97
ToppCell	Endothelial-endothelial_cell_of_lymph_vessel\|World / Lineage, Cell type, age group and donor	ERG MAP1B EBF1 PKHD1L1 RASIP1 PTPRB TNXB	1.59e-06	188	133	7	80910dcbb51990f2baed240f319456c0d3fa2065
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERG MAP1B EBF1 PKHD1L1 RASIP1 PTPRB TNXB	1.59e-06	188	133	7	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERG MAP1B EBF1 PKHD1L1 RASIP1 PTPRB TNXB	1.59e-06	188	133	7	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ERG MAP1B HIPK2 EBF1 PTPRB KLHL23 PLXNA2	1.70e-06	190	133	7	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ERG MAP1B PPFIA2 SPTB EBF1 HMCN1 KLHL23	1.70e-06	190	133	7	d6b3a92119b210974a32af3fe9875d60eb02761e
ToppCell	IPF-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	HIPK2 GSAP LIPC SLC15A4 KIR3DL2 IL2RB TTC38	1.76e-06	191	133	7	f2ddc0962007d7a4e78fbd916ebb62fc557d480a
ToppCell	LAM-Endothelial-LymEndo\|LAM / Condition, Lineage and Cell class	ERG MAP1B EBF1 PKHD1L1 RASIP1 PTPRB TNXB	1.89e-06	193	133	7	68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	ERG HIPK2 PKHD1L1 SNED1 PTPRB HMCN1 PLXNA2	1.89e-06	193	133	7	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	COPD-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	HIPK2 GSAP LIPC SLC15A4 KIR3DL2 IL2RB TTC38	1.89e-06	193	133	7	0020249fa71afb500af73700543bb6f349be6b10
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 PKHD1L1 SNED1 RASIP1 PTPRB EML1	1.89e-06	193	133	7	456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	ERG HIPK2 PKHD1L1 SNED1 PTPRB HMCN1 PLXNA2	1.89e-06	193	133	7	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	10x5'-blood-Lymphocytic_NK-NK_CD16\|blood / Manually curated celltypes from each tissue	HIPK2 IRF1 LLGL2 SLC15A4 KIR3DL2 IL2RB TTC38	1.96e-06	194	133	7	c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	ERG HIPK2 PKHD1L1 RASIP1 PTPRB HMCN1 PLXNA2	1.96e-06	194	133	7	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 RASIP1 FBLN2 PTPRB TNXB PLXNA2	1.96e-06	194	133	7	a429d22c8c9d0fd3bfa9f877a6364cecad68db30
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	IRF1 GSAP LLGL2 SLC15A4 KIR3DL2 IL2RB TTC38	1.96e-06	194	133	7	7773501e076d470158dbc1d7f10c67152b326eb7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 PKHD1L1 RASIP1 PTPRB EML1 TNXB	1.96e-06	194	133	7	ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 SNED1 RASIP1 PTPRB CIITA EML1	1.96e-06	194	133	7	e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCell	10x5'-blood-Lymphocytic_NK\|blood / Manually curated celltypes from each tissue	HIPK2 IRF1 LLGL2 SLC15A4 KIR3DL2 IL2RB TTC38	2.02e-06	195	133	7	c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 RASIP1 FBLN2 PTPRB EML1 PLXNA2	2.02e-06	195	133	7	d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 SNED1 RASIP1 PTPRB EML1 TNXB	2.09e-06	196	133	7	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG HLA-DRB5 EBF1 RASIP1 PTPRB CIITA EML1	2.09e-06	196	133	7	023312af38f816a44b407e0daa32590d953caf99
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PCBP3 ERG EBF1 SNED1 RASIP1 PTPRB EML1	2.09e-06	196	133	7	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ASXL1 HLA-DRB5 EBF1 PIKFYVE SNED1 FCRL5 IL2RB	2.09e-06	196	133	7	0175b097ad1338a07afebe3b5c7fd0bb0bb950f7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 SNED1 RASIP1 PTPRB EML1 TNXB	2.09e-06	196	133	7	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 RASIP1 FBLN2 PTPRB EML1 TNXB	2.09e-06	196	133	7	145fcf73deba9638b391a1af6c39fa205dc9829f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 RASIP1 PTPRB HMCN1 TNXB PLXNA2	2.09e-06	196	133	7	e224338490691d92c1f70b57112fabdcc92b06a9
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 RASIP1 PTPRB HMCN1 TNXB PLXNA2	2.17e-06	197	133	7	c10dd1aaec01fb662eac83dfde90e3e426665d65
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 SNED1 RASIP1 PTPRB EML1 TNXB	2.17e-06	197	133	7	0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERG CUBN SNED1 RASIP1 PTPRB HMCN1 PLXNA2	2.17e-06	197	133	7	9e948b2e0f7e426f1e6f95bbbf4282fbddc2b99d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 RASIP1 PTPRB HMCN1 TNXB PLXNA2	2.17e-06	197	133	7	2844dbcd0a673ed81c99920aa45858651a00736d
ToppCell	COVID-19_Severe-NK\|COVID-19_Severe / Disease condition and Cell class	HIPK2 GSAP LLGL2 SLC15A4 KIR3DL2 IL2RB TTC38	2.24e-06	198	133	7	742c4d6016cfa48444a5919a885ab8d02cad7e18
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG HLA-DRB5 EBF1 RASIP1 FBLN2 PTPRB TNXB	2.24e-06	198	133	7	b027a141ab531d0f5d6a26811a53427e7b0771dd
ToppCell	mild_COVID-19-NK\|World / disease group, cell group and cell class (v2)	STK17A IRF1 LLGL2 SLC15A4 KIR3DL2 IL2RB TTC38	2.24e-06	198	133	7	c0334e31772ab691be29cbaa78e43ee3b00425f5
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	ERG EBF1 RASIP1 PTPRB EML1 TNXB PLXNA2	2.24e-06	198	133	7	8689090bce9ab6e8f122426a404037e572c6713b
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	MXRA5 MAP1B FIGN SSC5D HMCN1 TNXB SDK1	2.24e-06	198	133	7	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	mild-B_memory\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HLA-DRB5 EBF1 PKHD1L1 PIKFYVE CIITA ILDR1 FCRL5	2.32e-06	199	133	7	e6ac9a0959b0de2c6a99298feb7715aa80ade1dd
ToppCell	Sigmoid-(5)_Dendritic_cell-(50)_cDC2\|Sigmoid / shred on region, Cell_type, and subtype	LILRA1 HLA-DQB2 HLA-DRB5 LRTM1 CEACAM4 CIITA SERPINF2	2.32e-06	199	133	7	402af84db90d8a49d67cf44c24766aefb00fd716
ToppCell	Control-NK\|Control / Disease condition and Cell class	HIPK2 GSAP LLGL2 SLC15A4 KIR3DL2 IL2RB TTC38	2.32e-06	199	133	7	f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MXRA5 MAP1B FIGN SNED1 SSC5D FBLN2 SNAI2	2.32e-06	199	133	7	21335475bbfbad8a6943b8076a6c1c67f3eec5d3
ToppCell	Sigmoid-Dendritic_cell-cDC2\|Sigmoid / Region, Cell class and subclass	LILRA1 HLA-DQB2 HLA-DRB5 LRTM1 CEACAM4 CIITA SERPINF2	2.32e-06	199	133	7	cd74db6db694b68f81dcf9d9342d125d00357ec1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PRTG ERG CUBN PLAC4 RASIP1 PTPRB HMCN1	2.32e-06	199	133	7	63c01e8961f48ed1bed4ab619cacf318cd6de7b9
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG SNED1 RASIP1 PTPRB SNAI2 EML1 TNXB	2.39e-06	200	133	7	b1be27d134a8633e3e7862c6a0d7be2001d387f0
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG MAP1B EBF1 RASIP1 FBLN2 PTPRB TNXB	2.39e-06	200	133	7	93e13937ec74418a697c37d56f57509fb2154780
ToppCell	Control-Control-Lymphocyte-T/NK-NK\|Control / Disease, condition lineage and cell class	STK17A HIPK2 GSAP LLGL2 KIR3DL2 IL2RB TTC38	2.39e-06	200	133	7	c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IL10RA STK17A IRF1 GSAP KIR3DL2 IL2RB TTC38	2.39e-06	200	133	7	48131c7c9444af84afb23184382d82e850acb445
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IL10RA STK17A IRF1 GSAP KIR3DL2 IL2RB TTC38	2.39e-06	200	133	7	755d65be8f05d4bf37c5dbe54948d2d8ab357d30
ToppCell	(5)_Fibroblast-E\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	MXRA5 MAP1B EBF1 IGSF10 FBLN2 SNAI2 TNXB	2.39e-06	200	133	7	75e5ecb05e965e24d569aa2ef5cdf740b1528c06
ToppCell	Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	MXRA5 EBF1 SSC5D FBLN2 HMCN1 SNAI2 TNXB	2.39e-06	200	133	7	d02e256b5d65a5c982ba5696bc7e077281ca3e24
ToppCell	COVID-19-kidney-Mito-rich_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ERG HIPK2 EBF1 RASIP1 PTPRB EML1	4.95e-06	145	133	6	afed661aef990edb8e7012ab67ace56443520c9f
ToppCell	Severe-B_naive-5\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MAP1B HAUS5 GREB1L HIPK3 PRKAB1 DCBLD2	6.73e-06	153	133	6	44572f87d403e314050ab935d2cd676c33d9c287
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERG FAM53A GDPD5 FBLN2 PTPRB ZMAT1	8.70e-06	160	133	6	33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 RASIP1 PTPRB EML1 TNXB	9.34e-06	162	133	6	c399b9e4854916a59f5cae2d8dbf19660f8759be
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Pre-B\|bone_marrow / Manually curated celltypes from each tissue	LINGO3 EBF1 FBLN2 TECPR2 TSPYL5 FCRL5	9.34e-06	162	133	6	e088e66aabc307dde5d2b9aa295c34ef68155b1a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 RASIP1 PTPRB EML1 TNXB	9.34e-06	162	133	6	5428c9fdb816f564395ebb4520448e5f3a42b025
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 RASIP1 PTPRB EML1 TNXB	9.34e-06	162	133	6	a291248b693c771845174393934a782f1d8bd7ce
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 SNED1 RASIP1 PTPRB EML1	9.67e-06	163	133	6	73c03e29a6d7a6863c5e9aa5e8b963ef691f1ddb
ToppCell	343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NECTIN3 UBE3D TSPYL5 NR3C2 BRICD5 SNAPC4	9.67e-06	163	133	6	0ab043b68e8739adcedda01165a3758cd0d22728
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ERG FBXL6 ARG1 FBLN2 PTPRB HMCN1	1.00e-05	164	133	6	3cd80e6275f0f9b5667912139d15ebf5e6b17f2f
ToppCell	COVID-19-lung-Mesothelial\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PCBP3 LRTM1 MUC16 RAET1E PKHD1L1 GDPD5	1.00e-05	164	133	6	83303e2ba52008391b8dc3fae8225ab5bcb20063
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 RASIP1 FBLN2 PTPRB PLXNA2	1.07e-05	166	133	6	8e2faca6a2e76a625de04d6098aa6f98911945c6
ToppCell	-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MXRA5 GREB1L FBLN2 FCRL5 KIR3DL2 TNXB	1.07e-05	166	133	6	bc9323de1373fdc0357e6bb46874f6c4787443a9
ToppCell	severe-Myeloid-mDC\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HLA-DQB2 HLA-DRB5 IGSF10 FBLN2 CIITA SERPINF2	1.11e-05	167	133	6	50b1cea9048bd8df9aff3fb9a548443f950d1090
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B GRID1 EBF1 FIGN SSC5D PLA2R1	1.15e-05	168	133	6	d19a115365c5415e51c039718d7669de788fcf33
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZNF618 LINGO3 NEO1 FBLN2 PTPRB SLC15A4	1.27e-05	171	133	6	943fbca8a6ac04052a2a85aca7b21a3461cd96f7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG EBF1 PKHD1L1 PTPRB CIITA EML1	1.31e-05	172	133	6	c056d44e2e130ceccadfcdceb192a7f095d779c8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG PKHD1L1 SNED1 RASIP1 PTPRB EML1	1.36e-05	173	133	6	f193c63cc536d891c9d23043765e320252bb6e65
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122\|Adult / Lineage, Cell type, age group and donor	ERG EBF1 PKHD1L1 RASIP1 PTPRB TNXB	1.36e-05	173	133	6	dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCell	Endothelial-B-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	ERG MAP1B EBF1 PKHD1L1 RASIP1 TNXB	1.36e-05	173	133	6	a81992965137195d20fc498f750975303961a828
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	RASIP1 PTPRB UBE3D FUT2 BCL2L13 EPHB1	1.40e-05	174	133	6	b4f3f5334803e5903bc496decf923f2e44f7fa3c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PKD1L1 RASIP1 PTPRB CIITA SNAI2 TNXB	1.45e-05	175	133	6	90302e8a44858ef3b2a165b88284d4788d591a99
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERG PPFIA2 LHFPL7 IGSF10 HMCN1 TMEM132A	1.50e-05	176	133	6	9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANSL1L ERG APBB1 RAET1E EBF1 ELK4	1.50e-05	176	133	6	29cda51a99100ddd2928cadc92da40f001d7e1f4
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	ERG MAP1B PKHD1L1 PTPRB TNXB EPHB1	1.50e-05	176	133	6	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERG PPFIA2 LHFPL7 IGSF10 HMCN1 TMEM132A	1.50e-05	176	133	6	3f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	ERG MAP1B PKHD1L1 PTPRB TNXB EPHB1	1.50e-05	176	133	6	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANSL1L ERG APBB1 RAET1E EBF1 ELK4	1.50e-05	176	133	6	01774a86d7d92f31a056b753f9844f923038003e
ToppCell	facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAP1B RAET1E PKHD1L1 FBLN2 PTPRB PLXNA2	1.59e-05	178	133	6	9f59a9af232d77bb55603a7776dbf9749ea652f2
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	ATP7A SLC2A9 HLA-DQB2 HLA-DRB5 CUBN CIITA	1.65e-05	179	133	6	99894067e2c2a3ed53abdc5434410c3172693496
ToppCell	Endothelial\|World / shred by cell class for turbinate	PRTG ERG EBF1 FBLN2 PTPRB TNXB	1.65e-05	179	133	6	052b2681974be00efb8503fa4e2c85d91d5ebd06
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HLA-DQB2 FBXL6 PTPRB LLGL1 TECPR2 FCRL5	1.65e-05	179	133	6	5be883d7d0be3180bb9844e4a757f0dd247294e4
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EBF1 LIPC CIITA TSPYL5 NR3C2 FCRL5	1.70e-05	180	133	6	c12c1cc206f7e63e5722471bd3eb84caddb84129
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EBF1 LIPC CIITA TSPYL5 NR3C2 FCRL5	1.70e-05	180	133	6	d8135f73a89b97168f2048258f4648e23536ece4
Disease	ubiquitin carboxyl-terminal hydrolase 25 measurement	HLA-DQB2 HLA-DRB5 USP8 TNXB	2.63e-06	22	132	4	EFO_0021881
Disease	vitamin B12 measurement	CUBN RASIP1 FUT2 SDK1	1.25e-05	32	132	4	EFO_0004620
Disease	rac GTPase-activating protein 1 measurement	HLA-DQB2 HLA-DRB5 USP8	1.87e-05	12	132	3	EFO_0801985
Disease	risk-taking behaviour	PRTG ZNF618 HLA-DQB2 FAM78B HLA-DRB5 EBF1 FIGN NEO1 KIAA2012 TNXB SDK1 PLXNA2 HTT	4.05e-05	764	132	13	EFO_0008579
Disease	basophil count	SLC2A9 ERG RBBP5 HLA-DQB2 HLA-DRB5 IRF1 CSF3 SLC15A4 PRKAB1 TNXB	6.63e-05	483	132	10	EFO_0005090
Disease	complement C4 measurement	HLA-DQB2 HLA-DRB5 USP8 TNXB	8.77e-05	52	132	4	EFO_0004984
Disease	Autosomal Recessive Hereditary Spastic Paraplegia	PQBP1 TECPR2	1.18e-04	4	132	2	C0751603
Disease	X-Linked, Spastic Paraplegia, Hereditary	PQBP1 TECPR2	1.18e-04	4	132	2	C0751605
Disease	Hereditary X-Linked Recessive Spastic Paraplegia	PQBP1 TECPR2	1.18e-04	4	132	2	C0751604
Disease	Henoch-Schoenlein purpura	HLA-DQB2 HLA-DRB5 FIGN	1.27e-04	22	132	3	EFO_1000965
Disease	Hereditary Autosomal Dominant Spastic Paraplegia	PQBP1 TECPR2	1.97e-04	5	132	2	C0751602
Disease	neuroblastoma (implicated_via_orthology)	LLGL2 LLGL1	1.97e-04	5	132	2	DOID:769 (implicated_via_orthology)
Disease	HMSN Type V	PQBP1 TECPR2	1.97e-04	5	132	2	C4721916
Disease	gdnf family receptor alpha-1 measurement	HLA-DQB2 TNXB	5.46e-04	8	132	2	EFO_0020400
Disease	asthma	HLA-DQB2 HLA-DRB5 MUC16 IRF1 GRID1 GSAP PIKFYVE FBLN2 CSF3 ILDR1 IL2RB	5.75e-04	751	132	11	MONDO_0004979
Disease	Epstein Barr virus nuclear antigen 1 IgG measurement	HLA-DQB2 HLA-DRB5	7.00e-04	9	132	2	EFO_0007790
Disease	bringing up phlegm, sputum or mucus on most days, self-reported	HLA-DRB5 FUT2	7.00e-04	9	132	2	EFO_0009824
Disease	HLA class II histocompatibility antigen, DQ alpha 2 chain measurement	HLA-DQB2 HLA-DRB5	7.00e-04	9	132	2	EFO_0801686
Disease	seropositivity measurement	HLA-DQB2 FUT2	7.00e-04	9	132	2	EFO_0007034
Disease	systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis	HLA-DQB2 IRF1 IL2RB	7.66e-04	40	132	3	EFO_1001999, EFO_1002019, EFO_1002020
Disease	hippocampal CA4 volume	PKD1L1 UBE3D TMEM132A	8.24e-04	41	132	3	EFO_0009396
Disease	lymphocyte percentage of leukocytes	ERG HLA-DQB2 IRF1 EBF1 CSF3 PRKAB1 FCRLB NR3C2 SNAPC4 BCL2L13	8.41e-04	665	132	10	EFO_0007993
Disease	acute necrotizing pancreatitis (implicated_via_orthology)	ARG1 SERPINF2	8.73e-04	10	132	2	DOID:0080998 (implicated_via_orthology)
Disease	CCL19 measurement	HLA-DQB2 HLA-DRB5	8.73e-04	10	132	2	EFO_0009415
Disease	secreted and transmembrane protein 1 measurement	HLA-DQB2 FUT2	8.73e-04	10	132	2	EFO_0021852
Disease	Inhalant adrenergic use measurement	HLA-DQB2 HLA-DRB5 MUC16 IRF1	9.25e-04	96	132	4	EFO_0009941
Disease	cortical surface area measurement	PRTG RBBP5 HIPK2 EML2 EBF1 NECTIN3 ARG1 NEO1 MTMR2 NR3C2 EML1 TNXB PLXNA2 SOS1 EPHB1	1.03e-03	1345	132	15	EFO_0010736
Disease	myeloid white cell count	ERG RBBP5 HLA-DRB5 EBF1 USP8 PLA2R1 LIPC CSF3 FCRL5 BCL2L13 DNASE1 HTT	1.05e-03	937	132	12	EFO_0007988
Disease	delta-5 desaturase measurement	PRTG EBF1	1.06e-03	11	132	2	EFO_0007764
Disease	autosomal dominant nonsyndromic deafness (is_implicated_in)	MAP1B GREB1L	1.06e-03	11	132	2	DOID:0050564 (is_implicated_in)
Disease	cAMP-specific 3',5'-cyclic phosphodiesterase 4D measurement	HLA-DQB2 TNXB	1.06e-03	11	132	2	EFO_0020224
Disease	kidney cancer (implicated_via_orthology)	LLGL2 LLGL1	1.06e-03	11	132	2	DOID:263 (implicated_via_orthology)
Disease	Gastric Adenocarcinoma	TEX14 WEE2 EPHB1	1.08e-03	45	132	3	C0278701
Disease	very low density lipoprotein cholesterol measurement	NRBF2 HLA-DQB2 RASIP1 NCOR2 LIPC FUT2	1.15e-03	260	132	6	EFO_0008317
Disease	serum non-albumin protein measurement	EBF1 GREB1L NCOR2 USP8 TECPR2 FCRLB FUT2	1.24e-03	361	132	7	EFO_0004568
Disease	serine protease 27 measurement	ERVK13-1 FUT2	1.27e-03	12	132	2	EFO_0008280
Disease	Night blindness, congenital stationary, type 1	LRIT3 GPR179	1.27e-03	12	132	2	C3501847
Disease	Night Blindness, Congenital Stationary, Type 1A	LRIT3 GPR179	1.27e-03	12	132	2	C3495587
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	LRIT3 GPR179	1.27e-03	12	132	2	C1864877
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	LRIT3 GPR179	1.27e-03	12	132	2	C1850362
Disease	X-Linked Csnb	LRIT3 GPR179	1.27e-03	12	132	2	C3711543
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	LRIT3 GPR179	1.27e-03	12	132	2	C1848172
Disease	neutrophil count	ERG HLA-DQB2 FAM78B HLA-DRB5 IRF1 TMC4 TEX14 PLA2R1 CSF3 PRKAB1 FCRL5 BCL2L13 TNXB DNASE1 HTT	1.34e-03	1382	132	15	EFO_0004833
Disease	Dupuytren Contracture	ERG IRF1 EBF1 SDK1	1.43e-03	108	132	4	EFO_0004229
Disease	Cone-rod synaptic disorder, congenital nonprogressive	LRIT3 GPR179	1.50e-03	13	132	2	C4041558
Disease	renal sinus adipose tissue measurement	SLC15A4 FCRL5	1.50e-03	13	132	2	EFO_0004864
Disease	hypothyroidism (implicated_via_orthology)	LIPC CS	1.50e-03	13	132	2	DOID:1459 (implicated_via_orthology)
Disease	level of Phosphatidylcholine (16:1_18:1) in blood serum	GREB1L LIPC	1.50e-03	13	132	2	OBA_2045082
Disease	C-C motif chemokine 19 measurement	HLA-DQB2 HLA-DRB5	1.74e-03	14	132	2	EFO_0008047
Disease	Spastic Paraplegia, Hereditary	PQBP1 TECPR2	1.74e-03	14	132	2	C0037773
Disease	phosphatidylcholine measurement	NRBF2 GREB1L NCOR2 LIPC CSF3 TNXB	1.79e-03	284	132	6	EFO_0010226
Disease	cleft lip	PRTG MUC16 EBF1 NCOR2 SSC5D LIPC	1.79e-03	284	132	6	EFO_0003959
Disease	tumor necrosis factor measurement	APBB1 LIPC	2.01e-03	15	132	2	EFO_0010834
Disease	Gastro-enteropancreatic neuroendocrine tumor	CIITA IL2RB	2.01e-03	15	132	2	C2930967
Disease	osteoarthritis (implicated_via_orthology)	ATP7A ERG	2.01e-03	15	132	2	DOID:8398 (implicated_via_orthology)
Disease	diffuse plaque measurement	PRTG RBBP5 GRID1 EBF1 GPR139 NCOR2 PLA2R1 FBLN2 MTMR2 KIR3DL2	2.22e-03	758	132	10	EFO_0010699
Disease	systemic lupus erythematosus, COVID-19	HLA-DQB2 FUT2 TNXB	2.26e-03	58	132	3	MONDO_0007915, MONDO_0100096
Disease	gout, hyperuricemia	SLC2A9 FAM53A	2.29e-03	16	132	2	EFO_0004274, EFO_0009104
Disease	aspartate aminotransferase measurement	RBBP5 HLA-DQB2 ERVK13-1 IRF1 CUBN RASIP1 NCOR2 USP8 LIPC KIAA2012 SOS1	2.52e-03	904	132	11	EFO_0004736
Disease	response to interferon-beta, anti-drug antibody measurement	HLA-DQB2 HLA-DRB5	2.58e-03	17	132	2	EFO_0010559, GO_0035456
Disease	Night blindness, congenital stationary	LRIT3 GPR179	2.58e-03	17	132	2	C0339535
Disease	hypertension	EBF1 FIGN NCOR2 USP8 NR3C2 TNXB	2.65e-03	307	132	6	EFO_0000537
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	NRBF2 HLA-DQB2 NCOR2 LIPC FUT2	2.87e-03	215	132	5	EFO_0008317, EFO_0008591
Disease	Hemangiosarcoma	PTPRB CSF3	2.90e-03	18	132	2	C0018923
Disease	fish consumption measurement	NOX3 EML1 SDK1	2.99e-03	64	132	3	EFO_0010139
Disease	carcinoma (implicated_via_orthology)	LLGL2 LLGL1 SNAI2	2.99e-03	64	132	3	DOID:305 (implicated_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	NRBF2 HLA-DQB2 NCOR2 LIPC FUT2	3.17e-03	220	132	5	EFO_0004529, EFO_0008317
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	HLA-DQB2 LIPC LLGL1	3.40e-03	67	132	3	EFO_0008595, EFO_0020946
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	NRBF2 HLA-DQB2 NCOR2 LIPC FUT2	3.42e-03	224	132	5	EFO_0004574, EFO_0008317
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	NRBF2 HLA-DQB2 NCOR2 LIPC FUT2	3.48e-03	225	132	5	EFO_0008317, EFO_0010351
Disease	MHC class I polypeptide-related sequence A measurement	HLA-DQB2 USP8 TNXB	3.55e-03	68	132	3	EFO_0008233
Disease	neoplasm of mature B-cells	HLA-DQB2 HLA-DRB5	3.58e-03	20	132	2	EFO_0000096
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	NRBF2 HLA-DQB2 NCOR2 LIPC FUT2	3.75e-03	229	132	5	EFO_0004639, EFO_0008317
Disease	Crohn's disease	HLA-DQB2 IRF1 GSAP RASIP1 PLA2R1 UBE3D FUT2	3.78e-03	441	132	7	EFO_0000384
Disease	alcohol consumption measurement	ZNF618 CLDN25 GRID1 NBEA GPR139 RASIP1 NCOR2 PTPRB NR3C2 FUT2 SDK1 PLXNA2 HTT	3.84e-03	1242	132	13	EFO_0007878
Disease	nephrotic syndrome	HLA-DQB2 HLA-DRB5 TNXB	4.01e-03	71	132	3	EFO_0004255
Disease	ulcerative colitis	HLA-DQB2 IRF1 CIITA SNAPC4 KIR3DL2 TNXB	4.06e-03	335	132	6	EFO_0000729
Disease	mean corpuscular hemoglobin concentration	ERG NRBF2 EP400 STK17A SPTB RTTN EBF1 INTS8 NEO1 MTMR2 KIAA2012 IL2RB	4.07e-03	1105	132	12	EFO_0004528
Disease	inflammatory bowel disease	HLA-DQB2 IRF1 PLA2R1 FUT2 KIR3DL2 TNXB PLXNA2	4.17e-03	449	132	7	EFO_0003767

Protein segments in the cluster

Peptide	Gene	Start	Entry
SWHTESLPVSLGPES	BCL2L13	261	Q9BXK5
SSRPLWHTVDQSPVL	CATSPERG	236	Q6ZRH7
TIVSPAHTPNWDLVS	EP400	2391	Q96L91
TASLLTFWHPPTTVQ	CEACAM4	21	O75871
PWESSPSIHIVNEVL	ERVK13-1	266	Q9NX77
VSTDRPWEASPSIHI	ERVK-18	326	O42043
RPWETSPSIHTLTEV	ERVK-19	441	O71037
RPWEASPSVHILTEV	ERVK-8	441	Q902F8
SQVLANLSWDTLHPP	SERPINF2	311	P08697
ATITVTPPQSNHSWA	BRICD5	91	Q6PL45
PTISTLPHGLWQISE	CIITA	231	P33076
VTWAVPVSDSNVPLL	FAM78B	146	Q5VT40
IVPADPTLWSTDHVR	ERG	126	P11308
ATTLLPVSWVAHATI	CLDN25	131	C9JDP6
EQWTPSHVSVAPATL	APBB1	576	O00213
ASQPALWHTVTLSSP	FBXL6	151	Q8N531
VSNSSLHWIPIPSND	ASXL1	891	Q8IXJ9
IWVDAHTDINTPLTT	ARG1	121	P05089
TVTASLTLPWDHIQS	ATP7A	91	Q04656
PTVSPVNASDIHWSS	RAET1E	206	Q8TD07
WSSLRTDHPTLTPAQ	RASIP1	851	Q5U651
ITAEHISIWPSSIPN	INTS8	791	Q75QN2
CAVSSTLPDWHIPVE	IRF1	186	P10914
HSLTGWSAPSNPLVI	KIR3DL2	101	P43630
LPPAAVTAVTLHTEW	LLGL1	596	Q15334
SIVNETSIILEWHPP	EPHB1	331	P54762
PITPLTTTWTSVIEH	MUC16	1536	Q8WXI7
WTVSIPLGSHPTTNT	MUC16	2201	Q8WXI7
PESTHTVDISTTPNW	MUC16	8211	Q8WXI7
TASWVIHPAETIPTV	MUC16	10596	Q8WXI7
TTWLTHPAETSSTIP	MUC16	10681	Q8WXI7
PETTATWLTHPAETS	MUC16	11571	Q8WXI7
TSTTTVEHAPIWRPG	NCOR2	1816	Q9Y618
WTPSLTLDTFTHPDT	PLAC4	56	Q8WY50
HSSPWTPSLLILDTL	PLAC4	126	Q8WY50
WPEQHFDITSTTRSP	FIGN	21	Q5HY92
TVWPDHGVPETTQSL	PTPRB	1866	P23467
IISPSPVHSTLNQWR	KANSL1L	671	A0AUZ9
HLPTSLGETWENLTI	LRTM1	136	Q9HBL6
LPPAWQQLTGVATHT	HIPK2	716	Q9H2X6
HLSSFPPVNTLVESW	NR3C2	546	P08235
LTSVSSLIVWHPANP	MAP1B	466	P46821
HPSVTSPLTVEWRAQ	HLA-DRB5	206	Q30154
QPPAVVTSLALHSEW	LLGL2	586	Q6P1M3
SHELQSVCPWETTAP	GPR179	1951	Q6PRD1
VEHPSLQSPITVEWR	HLA-DQB2	206	P05538
HNILSTSLPDAAWIP	FBLN2	386	P98095
IEPEWSIASGHTPLT	PLXNA2	1046	O75051
SWIQVQIPASHPVLT	FCRL5	276	Q96RD9
TILSVIWIESSLHQP	OR51L1	46	Q8NGJ5
NNTHTDTTIVWIFPP	P3R3URF	66	A0A087WWA1
SDSLHQQWLTPIPSR	ILDR1	346	Q86SU0
HASLETPWELTVHLP	KIAA2012	466	Q0VF49
TPWELTVHLPVDASR	KIAA2012	471	Q0VF49
DTVQTIIPWSTGPRH	LIPC	431	P11150
APTVAWVTPQHRPVT	LINGO3	436	P0C6S8
RIPVLSWIHPESQAT	MTMR2	266	Q13614
DNSHALSQVPSPLWI	GDPD5	476	Q8WTR4
HILHWTPIPNQSEST	IL10RA	41	Q13651
PTIHAIWSRPESTQV	GGPS1	216	O95749
TTLPPDFLESWTHLV	LRIT3	166	Q3SXY7
LTVSQIPSPQTWHVF	GPR180	111	Q86V85
QWLSSVETLLTNHPP	HAUS5	226	O94927
LTVHESLSSWTPLEP	GOLGA3	1451	Q08378
PSSSSLLPHADVAWV	GREB1L	1251	Q9C091
SVGIAHVVWPQPATT	HIPK3	746	Q9H422
RPWEASPSVHILTEV	ERVK-7	1201	P63135
ELWSLPPHAETATAS	NRBF2	226	Q96F24
AFWAPSVLPHSTLST	PCBP3	6	P57721
VAWHPVRPIIASISS	RBBP5	301	Q15291
EPQPTITWSRQGHSI	HMCN1	4466	Q96RW7
RLHVDQLSSPWSPVV	PRTG	796	Q2VWP7
DLVSWLSPHDPNSVV	PQBP1	71	O60828
TPLDESFQWLRHTTP	FANCD2OS	11	Q96PS1
SIPRSWPSAHSVSNI	PAX1	281	P15863
SNLPPTIISHSNKLW	CUBN	1126	O60494
AWQSLIHPDSSNTPL	PIKFYVE	271	Q9Y2I7
LLPHSSVLTWNTEIP	GSAP	486	A4D1B5
VSASTSPWVAAILPH	HTT	3061	P42858
HSTGIPDASISWVIP	IGSF10	596	Q6WRI0
THIQMLPTLWSEPSN	IGSF1	201	Q8N6C5
SDINEWSLITSSPHP	KLHL23	441	Q8NBE8
HSFIDLPTPSNISAW	MT-CYB	16	P00156
PWEASPSVHILTEVL	ERVK-24	331	P61566
RPWEASPSIHILTEV	ERVK-25	441	P61570
RPWEASPSVHILTEV	ERVK-6	441	Q69384
PWEASPSVHILTEVL	ERVK-7	331	P61567
LSSIHFWSTLSPVAP	ELK4	371	P28324
AAVTPRTVHLTWQPS	COL20A1	476	Q9P218
TVDQRLSSWHTDVPP	CEP97	641	Q8IW35
LSSWHTDVPPISSTL	CEP97	646	Q8IW35
WLIPDSADTTATPTH	DNASE1	216	P24855
LPVLHSATASRIPWQ	FUT2	111	Q10981
WLLVTGHIPTEEQVS	CS	121	O75390
IHVVTWNVASAAPPL	INPP5K	16	Q9BT40
TLSPGHTWEEAPLLT	IL2RB	171	P14784
WSELITPHAIRVQTP	EBF1	301	Q9UH73
HSALWTVQEATPLGP	CSF3	21	P09919
GTLTITLTLQDHAPW	SLC2A9	396	Q9NRM0
QPRPSASATLHSAIW	GRID1	596	Q9ULK0
RPWEASPSVHILTEV	HERVK_113	441	Q902F9
LPPHVRIWDSVTLNT	EML1	301	O00423
PPHVRIWDSVSLSTL	EML2	136	O95834
PQITASSVLEWTDHT	DCBLD2	306	Q96PD2
PVSDPIHLSVSNDWL	FCRLB	91	Q6BAA4
SIHTSIWITVPLTID	GPR139	111	Q6DWJ6
AVLASLLPIISWPHT	LHFPL7	161	Q6ICI0
ATLTVWNRTSIVHPP	SDK1	566	Q7Z5N4
NITTTPHTLPAAWLT	SLC15A4	356	Q8N697
QTSSQRVPLWPISHF	PKD1L1	226	Q8TDX9
VSIIESTWVSLEPIH	CDH16	231	O75309
PTSRTPSGNVWVTHE	PPFIA2	971	O75334
WHNKIVTIPPSITHV	LRRC8D	691	Q7L1W4
PWLPLTTTDRHVLSS	RTTN	176	Q86VV8
VPHPELSLAESLWTS	PWWP2A	246	Q96N64
CHWQPLDTVSSEIPA	TRNAU1AP	271	Q9NX07
TVPPWHPQSSLTLES	TEX14	951	Q8IWB6
LHVTAARPAQPTLWT	TMEM132A	296	Q24JP5
DSNSPHVWSLPSDLL	LILRA1	201	O75019
LSDQHPLTWRAVPQT	PRDM15	1461	P57071
NPAIWIHTPAKVQLS	NBEA	601	Q8NFP9
HVRPLVTSIVVSWTP	NEO1	746	Q92859
ITVWTTAAPFHAQLP	SNAI2	56	O43623
RWTSHTTATLTPQAP	SSC5D	691	A1L4H1
NITFQSSPPTVEWHI	SOS1	751	Q07889
SSLEWHPFTLTSAPQ	NOX3	331	Q9HBY0
LSSHSLFPVVPDESW	SOWAHB	356	A6NEL2
SEHPELCSETSIPWI	PLA2R1	1241	Q13018
LKHPWLTQSSIQEPS	STK17A	316	Q9UEE5
ESLATAPTHVWTRPL	SNED1	1091	Q8TER0
AVWVRHTSSEPQEPT	ACTL7A	41	Q9Y615
GQWTHDPSEPIVTSQ	PRKAB1	131	Q9Y478
PPCWNSVTDSLLLVH	ZNF618	691	Q5T7W0
SSIWAQIPESISSLP	TMC4	626	Q7Z404
LWESDISVHPLTLPS	UBE3D	341	Q7Z6J8
TPDSLHLSWTVPEGQ	TNXB	1171	P22105
TPVSALAASTHKPWL	TECPR2	726	O15040
RLSSSWESLQPEPSH	SPTB	2121	P11277
WDSNITPLVLAISPS	PKHD1L1	1061	Q86WI1
WVTASVTPSPRQALH	nan	101	A1L4Q6
ALSINPTDAWSVHTV	TTC38	206	Q5R3I4
PHVATSVPLPVTWVL	SNAPC4	1066	Q5SXM2
PWTPLSNVHELDTSS	WEE2	56	P0C1S8
KPWVLEVNISPSLHS	TTLL4	901	Q14679
ISPGVTASWIEAHLP	USP8	226	P40818
ITSSVPWTAELQLHG	TMEM234	126	Q8WY98
VENWNPLTDTVPIHS	TFIP11	536	Q9UBB9
SPVESQLPQWLPTHS	ZMAT1	371	Q5H9K5
VVSRSTPIQWLPGHD	TSPYL5	321	Q86VY4
SPVHPNLWASRESVT	FAM53A	346	Q6NSI3
DTFAHLTPTPTIWVN	MXRA5	996	Q9NR99
TTTLQPTIQWHPSTA	NECTIN3	361	Q9NQS3
PTIQWHPSTADIEDL	NECTIN3	366	Q9NQS3